The world’s first vaccine for mosquito-borne chikungunya virus has been approved by the UK’s Medicines and Healthcare ...

Sri Lanka is experiencing a rise in Chikungunya cases, with the highest number of infections being reported across the ...

The most common symptoms of chikungunya viral infection are fever and joint pain, often in the hands and feet. Other symptoms include muscle pain, headache, joint swelling, nausea, fatigue, and rash.

Valneva's Ixchiq vaccine – which was cleared in the EU, the US, and Canada last year – is currently indicated for preventing ...

At least five suspected cases of chikungunya were recorded in Davao City in January 2025. The residents who were suspected of ...

BHOPAL, Dec. 25 -- Madhya Pradesh is grappling with a rising number of Chikungunya cases, with the disease spreading rapidly despite crores of rupees spent annually to combat virus-borne illnesses.

Marketing authorization for the first EU vaccine to protect adolescents against chikungunya has been expedited for its public ...

Misdiagnosis continues to remain a major reason why this disease spreads Chikungunya shares symptoms with other mosquito-borne illnesses, such as dengue, including fever, rash, and joint pain.

The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 4 February 2025, approved the vaccine chikungunya vaccine (live) (brand name ...

Valneva has recieved Medicines and Healthcare products Regulatory Agency (MHRA) authorisation in the UK for the world’s first ...

The UK approval marks the fourth regulatory approval Valneva has received for its single-shot chikungunya vaccine. The vaccine is currently approved in the United States (U.S.) 2, Europe 3 and Canada ...

First chikungunya vaccine recommended by the CHMP for persons as young as 12 years old.The virus-like particle (VLP) single-dose chikungunya ...